Current State of Target Treatment in BRAF Mutated Melanoma

Incidence of melanoma has been constantly growing during the last decades. Although most of the new diagnoses are represented by thin melanomas, the number of melanoma-related deaths in 2018 was 60,712 worldwide (Global Cancer Observatory, 2019). Until 2011, no systemic therapy showed to improve sur...

詳細記述

書誌詳細

出版年:	Frontiers in Molecular Biosciences
主要な著者:	Enrica Teresa Tanda, Irene Vanni, Andrea Boutros, Virginia Andreotti, William Bruno, Paola Ghiorzo, Francesco Spagnolo
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2020-07-01
主題:	melanoma BRAF mutation targeted therapy MAPK pathway metastatic disease
オンライン･アクセス:	https://www.frontiersin.org/article/10.3389/fmolb.2020.00154/full